Repositorio Dspace

ListarNeurología Vascular por tema "Aspirin"

ListarNeurología Vascular por tema "Aspirin"

Ordenar por:Orden:Resultados:

  • Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial 
    Hart, Robert G.; Veltkamp, Roland C.; Sheridan, Patrick; Sharma, Mukul; Kasner, Scott E.; Bangdiwala, Shrikant I.; Ntaios, George; Shoamanesh, Ashkan; Ameriso, Sebastián Francisco; Toni, Danilo; Czlonkowska, Anna; Lindgren, Arne; Hankey, Graeme J.; Perera, Kanjana S.; Shuaib, Ashfaq; Coutts, Shelagh B.; Gagliardi, Rubens J.; Berkowitz, Scott D.; Mundl, Hardi; NAVIGATE ESUS Investigators (Elsevier, 2019-05-31)
    Background: Embolic stroke of undetermined source (ESUS) identifies patients with cryptogenic ischemic stroke presumed due to embolism from several unidentified sources. Among patients with recent ESUS, we sought to determine ...
  • Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy 
    Sharma, Mukul; Smith, Eric E.; Pearce, Lesly A.; Perera, Kanjana S.; Kasner, Scott E.; Yoon, Byung-Woo; Ameriso, Sebastián Francisco; Puig, Josep; Damgaard, Dorte; Fiebach, Jochen B.; Muir, Keith W.; Veltkamp, Roland C.; Toni, Danilo; Shamalov, Nikolay; Gagliardi, Rubens J.; Mikulik, Robert; Engelter, Stefan T.; Bereczki, Daniel; O'Donnell, Martin J.; Saad, Feryal (Sage, 2021-11-18)
    Background Covert brain infarcts are associated with important neurological morbidity. Their incidence in patients with embolic stroke of undetermined source (ESUS) is unknown. Aims To assess the incidence of covert ...
  • Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA 
    Johnston, S Claiborne; Amarenco, Pierre; Denison, Hans; Evans, Scott R; Himmelmann, Anders; James, Stefan; Knutsson, Mikael; Ladenvall, Per; Molina, Carlos A; Wang, Yongjun; THALES Investigators; Ameriso, Sebastián Francisco (Massachusetts Medical Society, 2020-07-16)
    Background: Trials have evaluated the use of clopidogrel and aspirin to prevent stroke after an ischemic stroke or transient ischemic attack (TIA). In a previous trial, ticagrelor was not better than aspirin in preventing ...

Buscar en DSpace


Listar

Mi cuenta